• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本的糖尿病肾病

Diabetic nephropathy in Japan.

作者信息

Shigeta Y, Kikkawa R

机构信息

Third Department of Medicine, Shiga University of Medical Science, Otsu, Japan.

出版信息

Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S191-7. doi: 10.1016/0168-8227(94)90248-8.

DOI:10.1016/0168-8227(94)90248-8
PMID:7859604
Abstract

According to a nation-wide survey of dialysis patients in Japan the number of diabetic patients with end-stage renal failure introduced to dialysis therapy has been increasing year by year, exceeding 6000 cases (28% of total cases) in 1991. A six-fold increase in numbers and a three-fold increase in percentages (DM/total) were observed in the past ten years. Although the medical technology and regimen in dialysis therapy have been greatly improved, the prognosis of those diabetic patients on maintenance dialysis has remained unsatisfactory. Their quality of life has been severely damaged mostly because of the impairment of visual acuity. The early detection and early introduction of effective therapy for diabetic nephropathy, therefore, may be the most imminent tasks necessary to prevent the various problems afflicting diabetic patients on end-stage renal failure.

摘要

根据一项针对日本透析患者的全国性调查,接受透析治疗的终末期肾衰竭糖尿病患者数量逐年增加,1991年超过6000例(占总病例的28%)。在过去十年中,数量增长了六倍,百分比(糖尿病患者/总病例)增长了三倍。尽管透析治疗的医疗技术和方案有了很大改进,但维持性透析的糖尿病患者预后仍不尽人意。他们的生活质量受到严重损害,主要是因为视力受损。因此,早期发现并尽早引入针对糖尿病肾病的有效治疗方法,可能是预防困扰终末期肾衰竭糖尿病患者的各种问题最紧迫的任务。

相似文献

1
Diabetic nephropathy in Japan.日本的糖尿病肾病
Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S191-7. doi: 10.1016/0168-8227(94)90248-8.
2
Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan.在日本早发性糖尿病中,2型糖尿病患者的糖尿病肾病发病率高于1型糖尿病患者。
Curr Hypertens Rep. 2001 Jun;3(3):177. doi: 10.1007/s11906-001-0035-5.
3
Treatment of end-stage renal failure due to diabetes in the United Kingdom.
J Diabetes Complications. 1992 Jan-Mar;6(1):1-6. doi: 10.1016/1056-8727(92)90041-i.
4
Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes.1型和2型糖尿病中糖尿病肾病患病率的趋势
Curr Opin Nephrol Hypertens. 2003 May;12(3):317-22. doi: 10.1097/00041552-200305000-00015.
5
Epidemiologic analysis of diabetic patients on chronic dialysis.接受长期透析的糖尿病患者的流行病学分析。
Nephron. 1996;74(2):361-6. doi: 10.1159/000189336.
6
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.2型糖尿病所致终末期肾衰竭:一场全球性的医学灾难。
Am J Kidney Dis. 1999 Nov;34(5):795-808. doi: 10.1016/S0272-6386(99)70035-1.
7
[Increasing number of dialysis-requiring patients with diabetic nephropathies. Better diabetes control and antihypertensive treatment can counteract the trend].[需要透析的糖尿病肾病患者数量不断增加。更好地控制糖尿病和进行抗高血压治疗可以抵消这一趋势]
Lakartidningen. 2005;102(18-19):1420-3.
8
Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories.2型(非胰岛素依赖型)糖尿病终末期肾衰竭的流行病学、发展及治疗。以法国本土及法属海外领地为例。
Diabetologia. 1993 Oct;36(10):1109-12. doi: 10.1007/BF02374507.
9
Epidemiology of diabetic nephropathy in Spain.西班牙糖尿病肾病的流行病学
Kidney Int Suppl. 2005 Dec(99):S20-4. doi: 10.1111/j.1523-1755.2005.09905.x.
10
[Natural history of diabetic nephropathy].[糖尿病肾病的自然病史]
Nihon Rinsho. 2005 Jun;63 Suppl 6:324-30.

引用本文的文献

1
Clinical impact of albuminuria in diabetic nephropathy.糖尿病肾病中蛋白尿的临床影响。
Clin Exp Nephrol. 2012 Feb;16(1):96-101. doi: 10.1007/s10157-011-0508-z. Epub 2011 Aug 10.
2
Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay.采用高灵敏度一步夹心酶免疫分析法检测糖尿病肾病患者尿Ⅳ型胶原的意义
J Clin Lab Anal. 1997;11(2):110-6. doi: 10.1002/(SICI)1098-2825(1997)11:2<110::AID-JCLA7>3.0.CO;2-F.